Drugmaker Incyte Corp reported fourth-quarter revenue above Wall Street estimates on Monday, boosted by strong demand for its key blood-cancer drug Jakafi and skin-disorder treatment Opzelura.

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...

The president of the University of Minnesota said a slash in funding for medical research grants by the National Institutes ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

Hornworts, a group of small and often overlooked plants, may hold the key to revolutionizing agriculture and combating ...

This eBook celebrates the achievements of inspiring women in life sciences, highlighting their journeys, challenges and ...